Cargando…
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma
An array of oncogenic histone point mutations have been identified across a number of different cancer studies. It has been suggested that some of these mutant histones can exert their effects by inhibiting epigenetic writers. Here, we report that the H3.3 G34R (glycine to arginine) substitution mut...
Autores principales: | Voon, Hsiao P. J., Udugama, Maheshi, Lin, Wendi, Hii, Linda, Law, Ruby H.P., Steer, David L., Das, Partha P., Mann, Jeffrey R., Wong, Lee H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081460/ https://www.ncbi.nlm.nih.gov/pubmed/30087349 http://dx.doi.org/10.1038/s41467-018-05607-5 |
Ejemplares similares
-
Histone H3.3 phosphorylation promotes heterochromatin formation by inhibiting H3K9/K36 histone demethylase
por: Udugama, Maheshi, et al.
Publicado: (2022) -
Coordinated maintenance of H3K36/K27 methylation by histone demethylases preserves germ cell identity and immortality
por: Zaghet, Nico, et al.
Publicado: (2021) -
KDM2B, an H3K36-specific demethylase, regulates apoptotic response of GBM cells to TRAIL
por: Kurt, Ibrahim Cagri, et al.
Publicado: (2017) -
The incorporation loci of H3.3K36M determine its preferential prevalence in chondroblastomas
por: Zhang, Yanjun, et al.
Publicado: (2021) -
The H3.3 K36M oncohistone disrupts the establishment of epigenetic memory through loss of DNA methylation
por: Sinha, Joydeb, et al.
Publicado: (2023)